arginine
esterase
cystic
fibrosis
pancreas
arginine
esterase
activity
chloroform
ellagic
acid
treated
plasma
patient
cystic
fibrosis
cf
age
matched
control
subject
resolved
component
fraction
ion
exchange
chromatography
deae
sephadex
electrofocusing
polyacrylamide
gel
activity
resolved
two
fraction
chromatography
one
inhibited
soybean
trypsin
inhibitor
sti
inhibited
sti
plasma
cf
patient
fraction
activity
inhibited
sti
reduced
approximately
corresponding
fraction
control
plasma
contrast
fraction
activity
resistant
inhibition
sti
show
significant
quantitative
difference
control
cf
plasma
sample
analysis
plasma
sample
electrofocusing
polyacrylamide
gel
range
ph
subsequent
staining
arginine
esterase
activity
showed
qualitative
difference
control
cf
plasma
sample
six
activity
band
could
detected
control
sample
whereas
five
band
detected
cf
sample
eight
sample
one
type
band
missing
two
another
type
band
missing
one
yet
another
type
band
missing
band
restricted
narrow
ph
zone
center
gel
data
consistent
extend
earlier
report
difference
arginine
esterase
activity
plasma
sample
cf
patient
control
subject
demonstration
absence
single
band
arginine
esterase
activity
consistent
absence
specific
arginine
esterase
isoenzyme
patient
cf
deficiency
arginine
esterase
patient
cystic
fibrosis
may
account
presence
factor
saliva
plasma
fibroblast
patient
consequently
clinical
manifestation
disease
